153 related articles for article (PubMed ID: 38613340)
1. Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer.
Zhang X; Qin Y; Chen X; Xiong M; Shu S
Technol Cancer Res Treat; 2024; 23():15330338241240683. PubMed ID: 38613340
[No Abstract] [Full Text] [Related]
2. Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival.
Farrag MS; Ibrahim EM; El-Hadidy TA; Akl MF; Elsergany AR; Abdelwahab HW
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1883-1889. PubMed ID: 34181347
[TBL] [Abstract][Full Text] [Related]
3. High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma.
Niu Y; Wang W; Jiang X; Huang Y; Yan S; Jiang Y
Jpn J Clin Oncol; 2022 Jul; 52(7):759-765. PubMed ID: 35348687
[TBL] [Abstract][Full Text] [Related]
4. Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy.
Ying H; Xu J; Zhang X; Liang T; Bai X
EBioMedicine; 2022 May; 79():103987. PubMed ID: 35439678
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
Lin G; Ye H; Wang J; Chen S; Chen X; Zhang C
Nephron; 2019; 141(4):256-264. PubMed ID: 30602154
[TBL] [Abstract][Full Text] [Related]
6. The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis.
Shimonosono M; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kijima Y; Kurahara H; Kita Y; Mori S; Sasaki K; Omoto I; Maemura K; Uenosono Y; Ishigami S; Natsugoe S
Oncotarget; 2018 Apr; 9(31):22069-22078. PubMed ID: 29774123
[TBL] [Abstract][Full Text] [Related]
7. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
Chen D; Chen W; Xu Y; Zhu M; Xiao Y; Shen Y; Zhu S; Cao C; Xu X
J Med Genet; 2019 Jan; 56(1):43-49. PubMed ID: 29967134
[TBL] [Abstract][Full Text] [Related]
8. The significance of immune-regulatory molecule B7-H4 in small cell lung cancer.
Zhang X; Song S; Zhang F; Cai L; Xie W
Ann Palliat Med; 2020 Jul; 9(4):1953-1957. PubMed ID: 32692215
[TBL] [Abstract][Full Text] [Related]
9. H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro.
Luo M; Xiong Y; Lin Y; Liang R; Li Y; Ge L
Med Sci Monit; 2021 May; 27():e930215. PubMed ID: 33990536
[TBL] [Abstract][Full Text] [Related]
10. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
[TBL] [Abstract][Full Text] [Related]
11. Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 Possesses Prognostic Significance and Promotes Progression of Papillary Thyroid Cancer.
Niu Y; Huang Y; Dong A; Sun Y
Int J Gen Med; 2022; 15():1509-1516. PubMed ID: 35210824
[TBL] [Abstract][Full Text] [Related]
12. HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer.
Wei L; Tang L; Chang H; Huo S; Li Y
Hum Cell; 2020 Jan; 33(1):116-122. PubMed ID: 31552567
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population.
Zhang C; Xu J; Ye J; Zhang X
Medicine (Baltimore); 2021 Jul; 100(30):e26789. PubMed ID: 34397730
[TBL] [Abstract][Full Text] [Related]
14. HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.
Cheng H; Janakiram M; Borczuk A; Lin J; Qiu W; Liu H; Chinai JM; Halmos B; Perez-Soler R; Zang X
Clin Cancer Res; 2017 Feb; 23(3):825-832. PubMed ID: 27553831
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance.
Gawesh ZM; Ibrahim EM; ElKalla HMHR; Awad AAH; Mohamed MA
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4309-4319. PubMed ID: 38156868
[TBL] [Abstract][Full Text] [Related]
16. Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer.
Zhang X; Xie W; Wang Z; Song S; Qin Y; Zhang F; Chen F; Cai L
Ann Transl Med; 2020 May; 8(9):589. PubMed ID: 32566616
[TBL] [Abstract][Full Text] [Related]
17. Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma.
Zhang MJ; Wang S; Wu CC; Wu L; Sun ZJ
J Oral Pathol Med; 2022 Apr; 51(4):379-387. PubMed ID: 35226778
[TBL] [Abstract][Full Text] [Related]
18. HHLA2 immune-regulatory roles in cancer.
Mortezaee K
Biomed Pharmacother; 2023 Jun; 162():114639. PubMed ID: 37011487
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
Zhang D; Xie J; Sun F; Xu R; Liu W; Xu J; Huang X; Zhang G
Cancer Lett; 2024 May; 589():216819. PubMed ID: 38522775
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]